Fig. 3: CDKPredX stratification and association with ORR12. | Nature Communications

Fig. 3: CDKPredX stratification and association with ORR12.

From: Neoadjuvant palbociclib and endocrine therapy versus chemotherapy in ER + /HER2- breast cancer: a randomized phase II trial

Fig. 3: CDKPredX stratification and association with ORR12.The alternative text for this image may have been generated using AI.

Clinical, histopathological and molecular characteristics of the CDKPredX+ and CDKPredX- groups in PREDIX LumB (A). Forest plots for the primary endpoint of ORR12 according to the CDKPredX predictor in PREDIX LumB and CORALLEEN (B). Odds ratios were estimated using logistic regression with two-sided Wald tests, interaction effects were evaluated using two-sided likelihood ratio tests, and no adjustment for multiple comparisons was applied. Source data are provided as a Source Data file.

Back to article page